Insmed | 营业费用



Operating Expenses 更改 日
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
DBV Technologies USD 27.37M 3M 2025-03
Dynavax Technologies USD 81.01M 10.78M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Insmed USD 361.29M 20.33M 2025-06
Novartis USD 10.15B 579M 2024-12
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


Insmed 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.